The biennial Symposium will bring together physicians treating these diseases; laboratory researchers studying genetics, genomics, and pathophysiology of bone marrow failure; and clinical investigators to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field.
Symposium Co-Chairs: Richard Stone, MD and Neal Young, MD.
Session Co-Chairs Include:
- Genetics and Genomics – Daria Babushok, MD, PhD and Marcin Wlodarski, MD, PhD
- Clonality in acquired BMF, PNH, and VEXAS – Emma Groarke, MD and Kohei Hosokawa, MD, PhD
- Advances in PNH – Rodrigo Calado, MD, PhD and Antonio Risitano, MD, PhD
- Transplantation for Marrow Failure – Amy DeZern, MD, MHS and Michael Pulsipher, MD
- Non-Transplant Therapies for Marrow Failure – Tim Olson, MD and Bhavisha Patel, MD
- Pathophysiology of MDS and Secondary AML – Jarek Maciejewski, MD, PhD, David Sallman, MD and Matthew Walter MD
- Treatments for MDS and Secondary AML – Andrew Brunner, MD and Jacqueline Garcia, MD
- MDS Classification and Prognosis – Robert Hasserjian, MD and Amer Zeidan, MD
